Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Institut Paoli-Calmettes, Marseille, France

Survival: 32.4 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Eloxatin
Country: France
City/State/Province: Marseille
Hospital: Institut Paoli-Calmettes
Journal: Link
Date: 3/2006

Patients: This phase II study involved a total of 105 patients and 98 who were eligible for a response with advanced pretreated platinum-sensitive ovarian cancer. The median age was 58.

Treatments: Patients received chemotherapy - paclitaxel followed by oxaliplatin every 21 days for a maximum of 9 cycles.

Toxicity: Toxicities included: grade 4 neutropenia, thrombocytopenia and hyperbilirubinemia and grade 3 neurotoxicity. In fact, a total of 67% of patients experienced grade 3-4 neutropenia.

Results: The overall survival was reported as 32.4 months.

Support: The study was supported by Sanofi-Synthelabo. This company manufactures and/or markets oxaliplatin.

Correspodence: Dr. A. Yovine

E-mail to a Friend Email Physician More Information